Global Infection Control Supplies Market Expected to Reach $106.1 Billion by 2035 Amid Rising Demand for PPE, Disinfection, and Sterilization Technologies

The global infection control supplies market is witnessing steady growth as health care systems intensify efforts to prevent the spread of infectious diseases. With rising hospital admissions, increasing surgical procedures, and growing awareness around hygiene and patient safety, infection control has become a cornerstone of modern health care delivery rather than a supplementary practice.

Valued at USD 56.4 billion in 2025, the market is projected to grow from USD 58.5 billion in 2026 to USD 106.1 billion by 2035, registering a CAGR of 6.8%. This sustained growth reflects the critical role of infection prevention solutions—including disinfectants, sterilization equipment, and personal protective equipment (PPE)—in ensuring clinical safety, regulatory compliance, and operational efficiency across health care settings.

Rising Burden of Infections Driving Market Demand

The increasing prevalence of health care-associated infections (HAIs) and surgical site infections remains a primary growth driver for the market. As health care systems globally manage higher patient volumes, the risk of infection transmission within hospitals and clinics continues to rise. This has led to greater demand for disinfectants, sterilization systems, and PPE to meet stringent infection control protocols.

In parallel, the growing geriatric population is significantly contributing to market expansion. Older adults, with comparatively weaker immune systems, require frequent medical interventions and hospital visits, thereby increasing their susceptibility to infections. This demographic trend is placing additional pressure on health care facilities to adopt robust infection prevention strategies.

The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions is further amplifying demand. These conditions often require prolonged treatments, surgeries, and hospital stays, increasing the likelihood of infection exposure and reinforcing the need for reliable infection control supplies.

Increasing Awareness Strengthening Adoption

Public and institutional awareness regarding infection prevention has grown considerably in recent years, particularly following global health crises. Governments and health care organizations are actively promoting hygiene protocols, leading to increased adoption of hand disinfectants, surface cleaners, and sterilization products across both health care and community settings.

Health care facilities are increasingly prioritizing adherence with infection control standards, not only to ensure patient safety but also to maintain accreditation and avoid regulatory penalties. This shift is translating into sustained investments in advanced infection control infrastructure.

Technological Advancements Transforming Infection Control

Technological innovation is playing a pivotal role in reshaping the infection control supplies market. The introduction of automated disinfection systems and advanced PPE solutions is enabling health care providers to enhance efficiency while reducing manual intervention.

Modern infection control technologies are transforming traditionally labor-intensive processes into streamlined, technology-driven workflows. Automated sterilization systems, touchless disinfection solutions, and real-time monitoring tools are improving accuracy, reducing human error, and ensuring consistent outcomes.

These advancements are particularly valuable in high-volume health care environments, where speed, reliability, and adherence are essential.

Challenges Limiting Market Penetration

Despite favorable growth dynamics, the market faces notable challenges, particularly in low-resource settings. Limited awareness regarding infection control practices among health care workers and patients continues to hinder adoption in certain regions.

Inadequate training and insufficient monitoring systems in smaller health care facilities can lead to improper use of disinfectants and sterilization equipment, reducing their effectiveness and compromising adherence to established protocols. Addressing these gaps remains critical for broader market penetration.

Emerging Opportunities in Outpatient Care Settings

The expansion of outpatient and ambulatory care facilities is creating new growth opportunities for infection control supply providers. As more procedures shift to ambulatory surgical centers (ASCs) and clinics, the need for cost-effective, efficient infection prevention solutions is growing.

These settings require compact, easy-to-use, and scalable infection control products, opening avenues for innovation and product diversification. Manufacturers focused on tailored solutions for outpatient environments are well-positioned to capitalize on this trend.

North America Leading with Strong Regulatory Framework

North America accounted for 42.5% of the global infection control supplies market in 2024, maintaining its leadership position due to advanced health care infrastructure and high awareness levels.

A key growth driver in the region is the high prevalence of healthcare-associated infections. According to estimates, approximately 1 in 31 hospitalized patients in the United States is affected by HAIs, highlighting the urgent need for effective infection prevention measures.

Stringent regulatory oversight by agencies such as the CDC, Occupational Safety and Health Administration (OSHA), and the Food and Drug Administration (FDA) ensures strict adherence to infection control standards. These regulations, coupled with supportive reimbursement policies and government initiatives, continue to drive consistent demand for infection control products.

Outlook: Advancing Toward Safer and Smarter Health Care Environments

The infection control supplies market is evolving in response to rising health care demands, increasing infection risks, and continuous technological innovation. As health care systems prioritize patient safety and operational efficiency, infection control will remain a fundamental component of care delivery.

Future growth will be driven by the adoption of automated, efficient, and user-friendly solutions across both hospital and outpatient settings. With ongoing advancements and increasing global awareness, the market is set to play a vital role in building safer, more resilient, and infection-free health care ecosystems worldwide.